Institute of Genetics and Biophysics Adriano Buzzati-Traverso, National Research Council of Italy, Naples, Italy.
Hum Mol Genet. 2013 Sep 15;22(18):3654-66. doi: 10.1093/hmg/ddt215. Epub 2013 May 16.
Focal segmental glomerulosclerosis (FSGS) is the consequence of a disease process that attacks the kidney's filtering system, causing serious scarring. More than half of FSGS patients develop chronic kidney failure within 10 years, ultimately requiring dialysis or renal transplantation. There are currently several genes known to cause the hereditary forms of FSGS (ACTN4, TRPC6, CD2AP, INF2, MYO1E and NPHS2). This study involves a large, unique, multigenerational Australian pedigree in which FSGS co-segregates with progressive heart block with apparent X-linked recessive inheritance. Through a classical combined approach of linkage and haplotype analysis, we identified a 21.19 cM interval implicated on the X chromosome. We then used a whole exome sequencing approach to identify two mutated genes, NXF5 and ALG13, which are located within this linkage interval. The two mutations NXF5-R113W and ALG13-T141L segregated perfectly with the disease phenotype in the pedigree and were not found in a large healthy control cohort. Analysis using bioinformatics tools predicted the R113W mutation in the NXF5 gene to be deleterious and cellular studies support a role in the stability and localization of the protein suggesting a causative role of this mutation in these co-morbid disorders. Further studies are now required to determine the functional consequence of these novel mutations to development of FSGS and heart block in this pedigree and to determine whether these mutations have implications for more common forms of these diseases in the general population.
局灶节段性肾小球硬化症(FSGS)是一种攻击肾脏过滤系统的疾病过程的结果,导致严重的瘢痕。超过一半的 FSGS 患者在 10 年内发展为慢性肾衰竭,最终需要透析或肾移植。目前已知有几个基因可导致 FSGS 的遗传性形式(ACTN4、TRPC6、CD2AP、INF2、MYO1E 和 NPHS2)。本研究涉及一个大型的、独特的、多代澳大利亚家系,其中 FSGS 与进行性心脏传导阻滞共分离,表现为明显的 X 连锁隐性遗传。通过经典的连锁和单体型分析联合方法,我们确定了 X 染色体上一个 21.19cM 的区间与该疾病有关。然后,我们使用全外显子组测序方法鉴定了两个突变基因,NXF5 和 ALG13,它们位于该连锁区间内。突变 NXF5-R113W 和 ALG13-T141L 在家系中与疾病表型完全分离,在一个大型的健康对照组中未发现。生物信息学工具分析预测 NXF5 基因中的 R113W 突变是有害的,细胞研究支持该蛋白的稳定性和定位作用,表明该突变在这些合并疾病中具有因果作用。目前需要进一步研究确定这些新突变对该家系 FSGS 和心脏传导阻滞的发生的功能后果,并确定这些突变是否对一般人群中这些疾病的更常见形式有影响。